Real-time enrollment status for this neoplasms, lung clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 4:49 PM UTC
| NCT Number | NCT07099898 |
| Recruiting Status | Recruiting |
| Condition | Neoplasms, Lung |
| Phase | PHASE3 |
| Target Enrollment | 420 participants |
| Active Locations | 4 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | September 28, 2026 (2 weeks ago) |
As of October 17, 2026: Clinical trial NCT07099898 is currently recruiting participants. This phase3 study for neoplasms, lung is actively seeking new participants at 4 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07099898 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07099898 was last updated 2 weeks ago (September 28, 2026). HelloStudys verifies this status automatically.